Cite
HARVARD Citation
Marini, B. et al. (2017). Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant. Journal of oncology pharmacy practice. pp. 255-263. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marini, B. et al. (2017). Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant. Journal of oncology pharmacy practice. pp. 255-263. [Online].